title: [Metastatic malignant melanoma in treated non-Hodgkin's lymphoma].
abstract: Secondary cutaneous neoplasia, e.g. basal cell malignant carcinomas or squamous cell carcinomas, is frequently observed in patients with malignant lymphomas. The association between malignant lymphoma and secondary malignant melanoma has only been rarely reported. We describe a patient with a low-grade nodal B-cell lymphoma who, while on treatment with steroids and an alkylating agent, developed a malignant melanoma level IV which rapidly metastasized to lymph nodes involved by the malignant lymphoma.
authors.affiliation: Praxen für Pathologie, Hämatologie/Onkologie und Dermatologie, Frankfurt am Main und Rüsselsheim.
authors.forename: S
authors.initials: S
authors.lastname: Falk
authors.forename: F
authors.initials: F
authors.lastname: Walther
authors.forename: R
authors.initials: R
authors.lastname: Denk
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D002699:Chlorambucil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis; D016393:Lymphoma, B-Cell / Q000188:drug therapy* / Q000473:pathology; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008545:Melanoma / Q000139:chemically induced* / Q000473:pathology; D009367:Neoplasm Staging; D009378:Neoplasms, Multiple Primary / Q000139:chemically induced* / Q000473:pathology; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000473:pathology
chemical_list: D002699:Chlorambucil; D011241:Prednisone